Jaromír Eiselt

953 total citations
25 papers, 332 citations indexed

About

Jaromír Eiselt is a scholar working on Nephrology, Hematology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Jaromír Eiselt has authored 25 papers receiving a total of 332 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Nephrology, 8 papers in Hematology and 4 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Jaromír Eiselt's work include Dialysis and Renal Disease Management (15 papers), Erythropoietin and Anemia Treatment (7 papers) and Iron Metabolism and Disorders (5 papers). Jaromír Eiselt is often cited by papers focused on Dialysis and Renal Disease Management (15 papers), Erythropoietin and Anemia Treatment (7 papers) and Iron Metabolism and Disorders (5 papers). Jaromír Eiselt collaborates with scholars based in Czechia, United States and Germany. Jaromír Eiselt's co-authors include Jaroslav Ráček, Ladislav Trefil, K Opatrný, Daniel Rajdl, Sylvie Opatrná, F Sefrna, Aleš Hořínek, Lukáš Kielberger, Marie Korabečná and Petr Pazdiora and has published in prestigious journals such as Annals of the New York Academy of Sciences, Clinical Chemistry and Laboratory Medicine (CCLM) and American Journal of Nephrology.

In The Last Decade

Jaromír Eiselt

24 papers receiving 320 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jaromír Eiselt Czechia 11 167 71 69 59 51 25 332
Masaaki Izumi Japan 12 153 0.9× 76 1.1× 34 0.5× 73 1.2× 100 2.0× 32 424
Aliza M. Thompson United States 8 130 0.8× 146 2.1× 145 2.1× 56 0.9× 44 0.9× 14 374
Ysamar Barrios Spain 12 68 0.4× 28 0.4× 91 1.3× 54 0.9× 44 0.9× 15 369
Hédi Ben Maïz Tunisia 10 137 0.8× 24 0.3× 35 0.5× 56 0.9× 55 1.1× 44 339
Filippo Mangione Italy 9 112 0.7× 61 0.9× 36 0.5× 33 0.6× 26 0.5× 16 269
Fumiko Sakata Japan 12 177 1.1× 23 0.3× 36 0.5× 77 1.3× 44 0.9× 19 309
Marek Kuźniewski Poland 12 185 1.1× 32 0.5× 37 0.5× 151 2.6× 60 1.2× 24 418
Ioannis Tsouchnikas Greece 8 140 0.8× 92 1.3× 26 0.4× 72 1.2× 24 0.5× 17 343
Zunsong Wang China 12 189 1.1× 25 0.4× 49 0.7× 58 1.0× 65 1.3× 32 384
Deepu Nair United States 7 98 0.6× 36 0.5× 63 0.9× 55 0.9× 43 0.8× 7 281

Countries citing papers authored by Jaromír Eiselt

Since Specialization
Citations

This map shows the geographic impact of Jaromír Eiselt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jaromír Eiselt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jaromír Eiselt more than expected).

Fields of papers citing papers by Jaromír Eiselt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jaromír Eiselt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jaromír Eiselt. The network helps show where Jaromír Eiselt may publish in the future.

Co-authorship network of co-authors of Jaromír Eiselt

This figure shows the co-authorship network connecting the top 25 collaborators of Jaromír Eiselt. A scholar is included among the top collaborators of Jaromír Eiselt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jaromír Eiselt. Jaromír Eiselt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Eiselt, Jaromír, et al.. (2016). Previous Vaccination and Age are More Important Predictors of Immune Response to Influenza Vaccine than Inflammation and Iron Status in Dialysis Patients. Kidney & Blood Pressure Research. 41(2). 139–147. 8 indexed citations
4.
Eiselt, Jaromír, et al.. (2014). Asymmetric Dimethylarginine and Progression of Chronic Kidney Disease - a One-Year Follow-Up Study. Kidney & Blood Pressure Research. 39(1). 50–57. 36 indexed citations
5.
Ráček, Jaroslav, et al.. (2013). Relationship between hepcidin and ferritin in haemodialysed patients. Wiener klinische Wochenschrift. 125(15-16). 448–452. 6 indexed citations
6.
Eiselt, Jaromír, et al.. (2010). High Ferritin, but Not Hepcidin, Is Associated with a Poor Immune Response to an Influenza Vaccine in Hemodialysis Patients. Nephron Clinical Practice. 115(2). c147–c153. 16 indexed citations
7.
Eiselt, Jaromír, et al.. (2010). Asymmetric Dimethylarginine in Hemodialysis, Hemodiafiltration, and Peritoneal Dialysis. Artificial Organs. 34(5). 420–425. 22 indexed citations
8.
Pejčoch, M, Petr Pazdiora, Jaromír Eiselt, et al.. (2010). Seroprevalence of hantavirus antibodies among chronic hemodialysis patients in the Czech Republic.. PubMed. 59(1). 48–51. 1 indexed citations
9.
Korabečná, Marie, et al.. (2008). Cell‐Free Plasma DNA during Peritoneal Dialysis and Hemodialysis and in Patients with Chronic Kidney Disease. Annals of the New York Academy of Sciences. 1137(1). 296–301. 47 indexed citations
10.
Ráček, Jaroslav, et al.. (2006). Brain Natriuretic Peptide and N-Terminal proBNP in Chronic Haemodialysis Patients. Nephron Clinical Practice. 103(4). c162–c172. 51 indexed citations
11.
Eiselt, Jaromír, et al.. (2006). The Effect of Intravenous Iron on Oxidative Stress in Hemodialysis Patients at Various Levels of Vitamin C. Blood Purification. 24(5-6). 531–537. 16 indexed citations
12.
Trefil, Ladislav, Daniel Rajdl, Jaroslav Ráček, et al.. (2005). Asymmetric dimethylarginine, homocysteine and renal function – is there a relation?. Clinical Chemistry and Laboratory Medicine (CCLM). 43(10). 1147–50. 6 indexed citations
13.
Opatrný, K, J Mareš, Sylvie Opatrná, et al.. (2002). Fibrinolysis Defect in Long-Term Hemodialysis Patients with Type 2 Diabetes mellitus and Its Relation to Metabolic Disorders. American Journal of Nephrology. 22(5-6). 429–436. 12 indexed citations
14.
Opatrný, K, Tomáš Reischig, Jörg Vienken, et al.. (2002). Does Treatment Modality Have an Impact on Anemia in Patients with Chronic Renal Failure? Effect of Low‐ and High‐Flux Biocompatible Dialysis. Artificial Organs. 26(2). 181–188. 12 indexed citations
15.
Eiselt, Jaromír, Jaroslav Ráček, Ladislav Trefil, & K Opatrný. (2001). Effects of a Vitamin E‐Modified Dialysis Membrane and Vitamin C Infusion on Oxidative Stress in Hemodialysis Patients. Artificial Organs. 25(6). 430–436. 34 indexed citations
16.
Eiselt, Jaromír, et al.. (1999). [Free radicals and extracorporeal renal replacement therapy].. PubMed. 45(5). 319–24. 5 indexed citations
18.
Eiselt, Jaromír, et al.. (1996). [The effect of acetate-free biofiltration on anemia and use of erythropoietin].. PubMed. 135(16). 525–9. 1 indexed citations
19.
Eiselt, Jaromír, et al.. (1996). [Does plasmapheresis affect the production of free radicals and the antioxidant system?].. PubMed. 135(17). 558–62. 3 indexed citations
20.
Eiselt, Jaromír, et al.. (1995). [Lipid peroxidation and the antioxidant system in bicarbonate hemodialysis and acetate-free biofiltration].. PubMed. 41(4). 235–9. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026